Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome

被引:24
|
作者
Jonker, L. A. [1 ]
Lebbink, C. A. [1 ,2 ]
Jongmans, M. C. J. [2 ,3 ]
Nievelstein, R. A. J. [2 ,4 ]
Merks, J. H. M. [2 ]
Nieveen van Dijkum, E. J. M. [5 ]
Links, T. P. [6 ]
Hoogerbrugge, N. [7 ]
van Trotsenburg, A. S. P. [8 ]
van Santen, H. M. [1 ,2 ]
机构
[1] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Endocrinol, POB 85090, NL-3508 AB Utrecht, Netherlands
[2] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Radiol & Nucl Med, Utrecht, Netherlands
[5] Univ Amsterdam, Med Ctr, Dept Surg, Canc Ctr Amsterdam, Amsterdam, Netherlands
[6] Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands
[7] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands
[8] Univ Amsterdam, Emma Childrens Hosp, Dept Pediat Endocrinol, Med Ctr, Amsterdam, Netherlands
关键词
Differentiated thyroid carcinoma; PTEN hamartoma tumor syndrome; pediatric; Thyroid carcinoma surveillance program; Thyroid cancer genetics; COWDEN SYNDROME; GERMLINE PTEN; PHOSPHATIDYLINOSITOL; 3-KINASE/AKT; CANCER; RISK; INDIVIDUALS; ADOLESCENTS; DISEASE;
D O I
10.1159/000508872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:PTEN hamartoma tumor syndrome (PHTS) represents a group of syndromes caused by a mutation in thePTENgene. Children with a germlinePTENmutation have an increased risk of developing differentiated thyroid carcinoma (DTC). Several guidelines have focused on thyroid surveillance in these children, but studies substantiating these recommendations are lacking.Objective:The present study intends to provide the available evidence for a thyroid carcinoma surveillance program in children with PHTS.Methods:An extensive literature search was performed to identify all studies on DTC in pediatric PHTS patients. Two pediatric cases are presented to illustrate the pros and cons of thyroid carcinoma surveillance. Recommendations for other patient groups at risk for DTC were evaluated. Consensus within the study team on recommendations for children with PHTS was reached by balancing the incidence and behavior of DTC with the pros and cons of thyroid surveillance, and the different surveillance methods.Results:In 5 cohort studies the incidence of DTC in childhood ranged from 4 to 12%. In total 57 cases of DTC and/or benign nodular disease in pediatric PHTS patients were identified, of which 27 had proven DTC, with a median age of 12 years (range 4-17). Follicular thyroid carcinoma (FTC) was diagnosed in 52% of the pediatric DTC patients. No evidence was found for a different clinical behavior of DTC in PHTS patients compared to sporadic DTC.Conclusions:Children with PHTS are at increased risk for developing DTC, with 4 years being the youngest age reported at presentation and FTC being overrepresented. DTC in pediatric PHTS patients does not seem to be more aggressive than sporadic DTC.Recommendations:Surveillance for DTC in pediatric PHTS patients seems justified, as early diagnosis may decrease morbidity. Consensus within the study team was reached to recommend surveillance from the age of 10 years onwards, since at that age the incidence of DTC seems to reach 5%. Surveillance for DTC should consist of yearly neck palpation and triennial thyroid ultrasound. Surveillance in children with PHTS should be performed in a center of excellence for pediatric thyroid disease or PHTS.
引用
收藏
页码:234 / 242
页数:9
相关论文
共 50 条
  • [31] Colonic manifestations of PTEN hamartoma tumor syndrome: Case series and systematic review
    Stanich, Peter P.
    Pilarski, Robert
    Rock, Jonathan
    Frankel, Wendy L.
    El-Dika, Samer
    Meyer, Marty M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (07) : 1833 - 1838
  • [32] PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young Female
    Ramkumar, Rathika R.
    Murthy, Prithvi B.
    Nguyen, Jane K.
    McKenney, Jesse
    Eng, Charis
    Campbell, Steven C.
    UROLOGY, 2021, 148 : 113 - 117
  • [33] PTEN Hamartoma tumor syndrome in childhood: A review of the clinical literature
    Macken, William L.
    Tischkowitz, Marc
    Lachlan, Katherine L.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2019, 181 (04) : 591 - 610
  • [34] Clinical Neurologic Features and Evaluation of PTEN Hamartoma Tumor Syndrome
    Dhawan, Andrew
    Baitamouni, Sarah
    Liu, Darren
    Eng, Charis
    NEUROLOGY, 2024, 103 (07)
  • [35] Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: Results of a multicenter cohort study
    Morgan, Frederick C.
    Yehia, Lamis
    McDonald, Christine
    Martinez-Agosto, Julian A.
    Hardan, Antonio Y.
    Tamburro, Joan
    Sahin, Mustafa
    Bayart, Cheryl
    Eng, Charis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (01) : 90 - 98
  • [36] Segmental storiform collagenomas: Expanding the spectrum of PTEN hamartoma tumor syndrome in children
    Habeshian, Kaiane
    Huppmann, Alison
    Ferreira, Carlos
    Kirkorian, A. Yasmine
    PEDIATRIC DERMATOLOGY, 2018, 35 (04) : E253 - E254
  • [37] Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients
    Laura Pena-Couso
    María Ercibengoa
    Fátima Mercadillo
    David Gómez-Sánchez
    Lucía Inglada-Pérez
    María Santos
    Javier Lanillos
    David Gutiérrez-Abad
    Almudena Hernández
    Pablo Carbonell
    Rocío Letón
    Mercedes Robledo
    Cristina Rodríguez-Antona
    José Perea
    Miguel Urioste
    Orphanet Journal of Rare Diseases, 17
  • [38] PTEN Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular Pathogenesis
    Innella, Giovanni
    Bonora, Elena
    Neri, Iria
    Virdi, Annalucia
    Guglielmo, Alba
    Pradella, Laura Maria
    Ceccarelli, Claudio
    Amato, Laura Benedetta
    Lanzoni, Anna
    Miccoli, Sara
    Gasparre, Giuseppe
    Zuntini, Roberta
    Turchetti, Daniela
    FRONTIERS IN MEDICINE, 2021, 8
  • [39] PTEN hamartoma tumor syndrome: Clinical and genetic characterization in pediatric patients
    Martin-Valbuena, Jesus
    Gestoso-Uzal, Nerea
    Justel-Rodriguez, Maria
    Isidoro-Garcia, Maria
    Marcos-Vadillo, Elena
    Lorenzo-Hernandez, Sandra Milagros
    Criado-Muriel, M. Carla
    Prieto-Matos, Pablo
    CHILDS NERVOUS SYSTEM, 2024, 40 (06) : 1689 - 1697
  • [40] Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome
    Hendricks, Linda A. J.
    Hoogerbrugge, Nicoline
    Mensenkamp, Arjen R.
    Brunet, Joan
    Lleuger-Pujol, Roser
    Hoberg-Vetti, Hildegunn
    Tveit Haavind, Marianne
    Innella, Giovanni
    Turchetti, Daniela
    Aretz, Stefan
    Spier, Isabel
    Tischkowitz, Marc
    Jahn, Arne
    Links, Thera P.
    Olderode-Berends, Maran J. W.
    Blatnik, Ana
    Leter, Edward M.
    Evans, D. Gareth
    Woodward, Emma R.
    Steinke-Lange, Verena
    Anastasiadou, Violetta C.
    Colas, Chrystelle
    Villy, Marie-Charlotte
    Benusiglio, Patrick R.
    Gerasimenko, Anna
    Barili, Valeria
    Branchaud, Maud
    Houdayer, Claude
    Tesi, Bianca
    Yazicioglu, M. Omer
    van der Post, Rachel S.
    Schuurs-Hoeijmakers, Janneke H. M.
    Vos, Janet R.
    van Hest, Liselotte P.
    Adank, Muriel A.
    Duijkers, Floor
    Nielsen, Maartje
    Verbeek, Katja C. J.
    van Ierland, Yvette
    Giltay, Jacques C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (01): : 93 - 103